Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: Case finding of asymptomatic individuals by EUS surveillance

Journal of Clinical Gastroenterology

Volumn 43, Issue 9, 2009, Pages 853-857

  Kluijt, Irma ^a   Cats, Annemieke ^a   Fockens, Paul ^b   Nio, Yung ^b   Gouma, Dirk J ^b   Bruno, Marco J ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CDKN2A; Endosonography; Familial pancreatic cancer; FAMMM syndrome; Surveillance

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; CANCER SURGERY; CASE FINDING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MARKER; DISEASE SURVEILLANCE; EARLY INTERVENTION; ENDOMETRIOSIS; ENDOSCOPIC ECHOGRAPHY; FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME; FAMILY; FEMALE; GENE MUTATION; HETEROZYGOTE; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MALIGNANT LENTIGO; MELANOMA; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; PROSTATE CANCER; SKIN CARCINOMA; VALVULAR HEART DISEASE; VON WILLEBRAND DISEASE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AGED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DYSPLASTIC NEVUS SYNDROME; EARLY DETECTION OF CANCER; ENDOSONOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MASS SCREENING; MIDDLE AGED; MUTATION; NETHERLANDS; PANCREATIC NEOPLASMS; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349684379     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181981123     Document Type: Article

References (27)

1. National Cancer Institute. Surveillance Epidemiology and End Results. Available at: URL: http://seer.cancer.gov/statfacts/ html/pancreas
2. Integrale kankercentra, Nederland. Kankerregistratie. Available at: URL: www.ikcnet.nl
3. Lal G, Liu G, Schmocker B, et al. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res. 2000; 60:409-416.
4. Lynch HT, Smyrk T, Kern SE, et al. Familial pancreatic cancer: a review. Semin Oncol. 1996;23:251-275.
5. Ghadirian P, Lynch HT, Krewski D. Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev. 2003;27: 87-93.
6. Lynch HT, Brand RE, Deters CA, et al. Hereditary pancreatic cancer. Pancreatology. 2001;1:466-471.
7. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119:1447-1453.
8. Ghadirian P, Liu G, Gallinger S, et al. Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas. Int J Cancer. 2002;97:807-810. (Pubitemid 34106336)
9. Giardiello FM, Offerhaus GJ, Lee DH, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut. 1993;34:1394-1396. (Pubitemid 23293626)
10. Lefrou L, Godart B, de Muret A, et al. Néomutation germinale du gene p53 chez un malade présentant un syndrome de Li- Fraumeni et un adénocarcubine du pancréas. Gastroentérol Clin Biol. 2006;30:484-486. (Pubitemid 44020157)
11. Lowenfels AB, Maisonneuve P, Whitcomb DC. Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. Med Clin North Am. 2000;84: 565-573.
12. Maisonneuve P, Marshall BC, Lowenfels AB. Risk of pancreatic cancer in patients with cystic fibrosis. Gut. 2007; 52:1327-1328. (Pubitemid 47300446)
13. Rulyak SJ, Lowenfels AB, Maisonneuve P, et al. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology. 2003;124:1292-1299. (Pubitemid 36531804)
14. Chari ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34:284-294. (Pubitemid 47176620)
15. Murphy KM, Brune KA, Griffin C, et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res. 2002;62:3789-3793. (Pubitemid 34728862)
16. Brentnall TA, Bronner MP, Byrd DR, et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med. 1999;131: 247-255. (Pubitemid 29383653)
17. Vasen HF, Gruis NA, Frants RR, et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer. 2000;87:809-811.
18. Goldstein AM, Fraser MC, Struewing JP, et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Eng J Med. 1995;333:970-974.
19. Whelan AJ, Bartsch D, Goodfellow PJ. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med. 1995; 333:975-977.
20. Goggins M, Canto M, Hruban R. Can we screen high-risk individuals to detect early pancreatic carcinoma? J Surg Oncol. 2000;74:243-248.
21. Bartsch DK, Sina-Frey M, Lang S, et al. CDKN2A germline mutations in familial pancreatic cancer. Ann Surg. 2002; 236:730-737. (Pubitemid 35403228)
22. Goggins M. Identifying molecular markers for the early detection of pancreatic neoplasia. Semin Oncol. 2007;34: 303-310. (Pubitemid 47176618)
23. Lynch HT, Brand RE, Lynch JF, et al. Hereditary factors in pancreatic cancer. J Hepatobiliary Pancreat Surg. 2002;9: 12-31.
24. Canto MI. Strategies for screening for pancreatic adenocarcinoma in high-risk patients. Semin Oncol. 2007;34: 295-302. (Pubitemid 47176623)
25. Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: improvements in our understanding of genetics and screening. Int J Biochem Cell Biol. 2004;36:1386-1392.
26. McFaul CD, Greenhalf W, Earl J, et al. Anticipation in familial pancreatic cancer. Gut. 2006;55:252-258.
27. Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR, et al. Inherited predisposition to pancreatic cancer. Gut. 2001;48: 143-147.